- Home
- RGNX vs CPS Comparison
RGNX vs CPS Comparison
Compare RGNX & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | CPS |
|---|---|---|
| Founded | 2008 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 544.9M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RGNX | CPS |
|---|---|---|
| Price | $6.21 | $29.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $28.75 | ★ $51.88 |
| AVG Volume (30 Days) | ★ 1.1M | 171.8K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.08 | ★ 94.87 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | $4.42 |
| Revenue Next Year | $19.08 | $6.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $6.02 | $20.10 |
| 52 Week High | $16.19 | $47.98 |
Technical Indicators
Market Signals| Indicator | RGNX | CPS |
|---|---|---|
| Relative Strength Index (RSI) | 28.35 | 43.86 |
| Support Level | N/A | $28.31 |
| Resistance Level | $9.67 | $31.92 |
| Average True Range (ATR) | 0.76 | 1.90 |
| MACD | -0.16 | -0.12 |
| Stochastic Oscillator | 4.30 | 8.12 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.